BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ott, M
Right arrow Articles by Schmidberger, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ott, M
Right arrow Articles by Schmidberger, H
British Journal of Radiology 75 (2002),514-517 © 2002 The British Institute of Radiology

Full Paper

Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?

M Ott, MD 1 N Breiter, MD 2 C F Albrecht, MD 1 O Pradier, MD 1 C F Hess, MD, PhD 1 and H Schmidberger, MD 1

Departments of 1 Radiotherapy and 2 Neuroradiology, University Hospital, 37075 Göttingen, Germany

Correspondence: Dr Marcel Ott, Universitätsklinik, Abt. Strahlentherapie, Robert-Koch-Str. 40, 37075 Göttingen, Germany

The purpose of this study was to try to determine by means of contrast-enhanced MRI, a subset of patients with Graves' ophthalmopathy who will not respond to orbital radiotherapy. 54 patients with Graves' ophthalmopathy were treated with orbital radiotherapy (10 x 2 Gy) and symptom relief was recorded. MRI examinations prior to radiotherapy were retrospectively evaluated for enlargement, contrast enhancement and fibrotic changes in extraocular muscles and surrounding soft tissue. Imaging data were correlated with clinical features and response. Symptom relief was observed in 61% of patients but this could not be predicted by any of the MRI signs investigated. However, there is a trend for a better treatment reponse in patients who show contrast enhancement of extraocular muscles prior to orbital radiotherapy (p=0.08). MRI could not adequately predict the efficacy of orbital radiotherapy in this group of patients. Clinical assessment of disease activity is still the most reliable method.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2002 by the British Institute of Radiology.